Skip to main content
Premium Trial:

Request an Annual Quote

Modular Genetics Closes First Round of $5.5M Series B Financing

NEW YORK, June 30 (GenomeWeb News) - Modular Genetics has closed the first round of a $5.5 million Series B financing, the Woburn, Mass.-based company said today.


According to an official statement, Modular Genetics will use the cash to enhance its automated gene engineering system, expand its sales force, and accelerate specific product development programs.


Molecular Genetics' core technology, CombiGenix, is used for automated assembly and modification of cloned genes, and is the basis of three of the company's gene engineering platforms: GeneDirect, a 96-sample platform for site-directed mutagenesis; GeneBuild, for codon optimization and assembly of custom genes; and GeneFix, for repairing mutations or removing introns from cloned genes.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.